A Risk Score Based on Immune- and Oxidative Stress-Related LncRNAs Predicts Prognosis in Lung Adenocarcinoma: Insights from in vitro Experiments and Large-Scale Transcriptome Analysis
Xin Liu,Fangchao Zhao,Xiaodan Wang,Zheng Ma,Hongjiang Yan,Xuchao Lu,Shujun Li,Haiyong Zhu,Shaolin Gao
DOI: https://doi.org/10.2147/jir.s428287
IF: 4.5
2024-03-05
Journal of Inflammation Research
Abstract:Xin Liu, 1, &ast Fangchao Zhao, 2, &ast Xiaodan Wang, 2, &ast Zheng Ma, 2 Hongjiang Yan, 2 Xuchao Lu, 2 Shujun Li, 2 Haiyong Zhu, 2, &ast Shaolin Gao 2 1 Second Department of Pulmonary and Critical Care Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China; 2 Department of Thoracic Surgery, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China &astThese authors contributed equally to this work Correspondence: Shaolin Gao, Department of Thoracic Surgery, The Second Hospital of Hebei Medical University, No. 215 Heping West Road, Shijiazhuang, Hebei, People's Republic of China, Tel/Fax +86-311-66003588, Email Background: Long non-coding RNAs (lncRNAs) were demonstrated to be key to cancer progression and highly associated with the tumor immune microenvironment. Oxidative stress and immune may modulate the biological behaviors of tumors. Therefore, biomarkers that combined oxidative stress, immune, and lncRNA can be a promising candidate bioindicator in clinical therapy of cancers. Methods: Immune-related genes (IRGs) and oxidative stress-related genes (ORGs) were identified based on a detailed review of published literatures. The transcriptome data and clinical information of lung adenocarcinoma (LUAD) patients were obtained from TCGA database. Lasso and Cox regression analyses were conducted to develop a prognostic model. Additionally, the link between immune checkpoints, immune cells, and the prognostic model was investigated, and predict the sensitivity of immunotherapy. Results: 2498 IRGs and 809 ORGs were extracted from previous studies, and 190 immune- and oxidative stress-related genes (IOGs) were acquired by overlapping the above genes. 658 immune- and oxidative stress-related lncRNAs (IOLs) were screened by Pearson correlation analysis. A total of 25 prognosis-related IOLs were screened by univariate regression analysis. Finally, LASSO Cox regression analysis was adopted for determining a 12-IOLs prognostic risk signature. The signature performance was confirmed in the training cohort and the testing cohort, and cases were classified into low- and high-risk groups by the risk score calculated from the signature. Patients in the high-risk group had poor prognoses and immunosuppression, while the risk score was significantly associated with tumor-infiltrating immune cells, immune checkpoint expression, and immunotherapy responses. In vitro experiments further confirmed the expression of key signature gene. Conclusion: Our new IOLs-related prognostic signature can be reliable prognostic tools and therapeutic targets for LUAD patients. Keywords: immune, oxidative stress, lung adenocarcinoma, prognostic model Based on data obtained from the National Cancer Center, it is evident that lung cancer holds the distinction of being the most prevalent malignant tumor and leading cause of cancer-related fatalities in China. 1 In terms of tissue type, lung cancer can primarily be categorized into two main types: non-small cell lung cancer (NSCLC) and small cell lung cancer. Of these, NSCLC is the most common, with lung adenocarcinoma (LUAD) emerging as the primary histological subtype. 2,3 Unfortunately, early-stage LUAD cases typically lack typical clinical symptoms and signs, resulting in most cases being diagnosed at middle and late stages and leading to a poor overall prognosis. 4 Despite the increasing maturity and perfection of LUAD treatment technology and strategy in China, the overall 5-year survival rate remains low. 5 Therefore, predictive biomarkers with high reliability and corresponding predictive models are essential for individualized treatment and early, accurate diagnosis of LUAD cases. Oxidative stress occurs due to the accumulation of reactive nitrogen and reactive oxygen species (ROS) in cells and organs under certain special conditions, resulting in oxidative damage when the body's oxidation-reduction balance is imbalanced and free radicals exceed the range of antioxidant scavenging capacity. 6 Oxidative stress plays a crucial role in tumor metastasis/invasion, tumor progression, carcinogenesis, and acute/chronic inflammation in the tumor microenvironment (TME). 7,8 Immune cells are highly sensitive to oxidative stress due to their high content of unsaturated fatty acids in their cell membranes, making them susceptible to peroxidation reactions. As a result, excess free radicals can decrease immune function, leading to immune system dysfunction. 9 In summary, oxidative -Abstract Truncated-
immunology